0001723963-21-000004.txt : 20210706 0001723963-21-000004.hdr.sgml : 20210706 20210706170753 ACCESSION NUMBER: 0001723963-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210706 DATE AS OF CHANGE: 20210706 EFFECTIVENESS DATE: 20210706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BreStem Therapeutics, Inc. CENTRAL INDEX KEY: 0001723963 IRS NUMBER: 821935111 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-405341 FILM NUMBER: 211075002 BUSINESS ADDRESS: STREET 1: 1001 WILLIAM MOORE DRIVE CITY: RALEIGH STATE: NC ZIP: 27606 BUSINESS PHONE: 919-513-6157 MAIL ADDRESS: STREET 1: 1001 WILLIAM MOORE DRIVE CITY: RALEIGH STATE: NC ZIP: 27606 D 1 primary_doc.xml X0708 D LIVE 0001723963 BreStem Therapeutics, Inc. 1001 WILLIAM MOORE DRIVE RALEIGH NC NORTH CAROLINA 27606 310-614-9161 NORTH CAROLINA None None Corporation true 2017 Ke Cheng c/o BreStem Therapeutics, Inc. 1001 William Moore Drive RALEIGH NC NORTH CAROLINA 27606 Executive Officer Director Weili Zhou c/o BreStem Therapeutics, Inc. 1001 William Moore Drive RALEIGH NC NORTH CAROLINA 27606 Director Weigang Wang c/o BreStem Therapeutics, Inc. 1001 William Moore Drive RALEIGH NC NORTH CAROLINA 27606 Director Other Health Care Decline to Disclose 06b false 2021-06-21 false true true false 0 2000000 250000 1750000 false 1 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false BreStem Therapeutics, Inc. /s/ Ke Cheng Ke Cheng Chief Executive Officer 2021-07-06